Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998.
paper
Cited
Public
Unavailable
- Authors
- Kral, Alex H; Lorvick, Jennifer; Gee, Lauren; Bacchetti, Peter; Rawal, Bhupat; Busch, Michael; Edlin, Brian R
- Year
- 2003
- Journal
- American journal of epidemiology
- PMID
- 12746244
- DOI
- 10.1093/aje/kwg070
This paper reports trends in human immunodeficiency virus (HIV) incidence among street-recruited injection drug users (IDUs) in San Francisco, California, from 1987 through 1998, estimated using a sensitive/less sensitive enzyme immunoassay testing strategy. IDUs were enrolled in 23 semiannual cross-sections from three community sites. For identification of recent infections, less sensitive enzyme immunoassay testing was performed on stored specimens that had previously tested positive for HIV antibodies. Annualized incidence rates were calculated and logistic regression models were fitted for assessment of risk factors for recent HIV infection. Among 8,065 susceptible IDUs, 34 had recent infections, for an incidence rate of 1.2% (95% confidence interval: 0.7, 2.0) per person-year. This rate declined from 2.7% in 1987/1988 to approximately 1% per person-year between 1989 and 1998. Two IDU subpopulations were at highest risk for infection: persons under age 30 years (2.8% per person-year) and men who had sex with men (3.0% per person-year). Participants who reported prior HIV test-result counseling were less likely than others to become infected (adjusted odds ratio = 0.43, 95% confidence interval: 0.21, 0.87). Sensitive/less sensitive enzyme immunoassay testing is an effective tool for assessing HIV incidence. HIV incidence among street-recruited IDUs in San Francisco appears to have remained stable and moderate since the late 1980s.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Brief Report: HIV Incidence Among People Who Inject Drugs, San Francisco, 2022. | Elbur AI et al. | β | 2025 | β |
| Examining trends in the incidence of HIV infection among people with a history of drug use to inform an outbreak investigation and response: A retrospective cohort study. | Trayner KMA et al. | β | 2025 | β |
| Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. | Artenie A et al. | β | 2023 | β |
| Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQΞ²1. | Valencia A et al. | β | 2022 | β |
| Characterizing Men Who Have Sex with Men and Use Injection Drugs in Vancouver, Canada. | Scheim A et al. | β | 2019 | β |
| Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. | Vergara C et al. | β | 2019 | β |
| HIV Incidence Among Men Who Have Sex with Men and Inject Drugs in a Canadian Setting. | Scheim AI et al. | β | 2018 | β |
| Measures of human immunodeficiency virus (HIV) community viral load and HIV incidence among people who inject drugs. | Glasheen C et al. | β | 2018 | β |
| Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. | Lambdin BH et al. | β | 2017 | β |
| Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens. | Sypsa V et al. | β | 2017 | β |
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | Johnson EO et al. | β | 2016 | β |
| Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients. | HernΓ‘ndez D et al. | β | 2016 | β |
| Associations of common variants in the BST2 region with HIV-1 acquisition in African American and European American people who inject drugs. | Hancock DB et al. | β | 2015 | β |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | β | 2015 | β |
| Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study. | Johnson EO et al. | β | 2015 | β |
| Replication of ZNF804A gene variant associations with risk of heroin addiction. | Hancock DB et al. | β | 2015 | β |
| Activity spaces among injection drug users in San Francisco. | Martinez AN et al. | β | 2014 | β |
| Can hepatitis C be eradicated in the United States? | Edlin BR et al. | β | 2014 | β |
| Spatial analysis of HIV positive injection drug users in San Francisco, 1987 to 2005. | Martinez AN et al. | β | 2014 | β |
| Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco. | Lopez AM et al. | β | 2013 | β |
| Low-frequency heroin injection among out-of-treatment, street-recruited injection drug users. | Harris JL et al. | β | 2013 | β |
| Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling. | Malekinejad M et al. | β | 2011 | β |
| Changes in blood-borne infection risk among injection drug users. | Mehta SH et al. | β | 2011 | β |
| HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. | Etcheverry MF et al. | β | 2011 | β |
| Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada. | Roy E et al. | β | 2011 | β |
| Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study. | Bruneau J et al. | β | 2011 | β |
| Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. | Kral AH et al. | β | 2010 | β |
| HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. | Gough E et al. | β | 2010 | β |
| HIV and risk environment for injecting drug users: the past, present, and future. | Strathdee SA et al. | β | 2010 | β |
| Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. | Solomon SS et al. | β | 2010 | β |
| Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. | Stall R et al. | β | 2009 | β |
| Testing bias in calculating HIV incidence from the Serologic Testing Algorithm for Recent HIV Seroconversion. | Remis RS et al. | β | 2009 | β |
| The changing landscape of crack cocaine use and HIV infection. | Celentano D et al. | β | 2009 | β |
| The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users. | Gyarmathy VA et al. | β | 2009 | β |
| High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. | Solomon SS et al. | β | 2008 | β |
| Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. | Page-Shafer K et al. | β | 2008 | β |
| Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. | Heimer R et al. | β | 2007 | β |
| Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis. | Bluthenthal RN et al. | β | 2007 | β |
| Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. | Bacchetti P et al. | β | 2007 | β |
| Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors. | Barrio G et al. | β | 2007 | β |
| Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. | Tseng FC et al. | β | 2007 | β |
| Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. | Lindenburg CE et al. | β | 2006 | β |
| Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. | Page JB et al. | β | 2006 | β |
| HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). | Mehta SH et al. | β | 2006 | β |
| Mathilde Krim, amfAR, and the prevention of HIV infection among injecting drug users: a brief history. | Des Jarlais DC | β | 2006 | β |
| Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. | Bourgois P et al. | β | 2006 | β |
| Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. | Heinzerling KG et al. | β | 2006 | β |
| Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. | Santibanez SS et al. | β | 2006 | β |
| HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. | Des Jarlais DC et al. | β | 2005 | β |
| HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. | Kral AH et al. | β | 2005 | β |
| Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. | Gunn RA et al. | β | 2005 | β |
| The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. | Blower S et al. | β | 2005 | β |
| HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study. | Hahn JA et al. | β | 2004 | β |
| Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. | Tsui R et al. | β | 2004 | β |
| Injection drug use among stimulant users in a national sample. | Wu LT et al. | β | 2004 | β |
| Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. | Kral AH et al. | β | 2004 | β |
| The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions. | Kuyper LM et al. | β | 2004 | β |